Skip to main content
. 2021 Mar 5;8:644053. doi: 10.3389/fmed.2021.644053

Figure 3.

Figure 3

Immune checkpoints and small molecular drugs in ovarian cancer. (A) Box plots for the associations between subtypes and immune checkpoints in ovarian cancer. Ns, not significant; **p < 0.01; ***p < 0.001. (B) Heatmap showing small inhibitors (perturbagen) and their shared mechanisms of action (rows) from the CMap database.